Form 6-K ZTO Express (Cayman) For: Oct 05

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2026

 

 

Commission File Number: 001-37922

 

 

ZTO Express (Cayman) Inc.

 

Building One, No. 1685 Huazhi Road

Qingpu District

Shanghai, 201708

People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F ¨

 

 

 

Exhibit Index

 

Exhibit 99.1 — Next Day Disclosure Return Dated September 29, 2026

Exhibit 99.2 — Next Day Disclosure Return Dated September 30, 2026

Exhibit 99.3 — Next Day Disclosure Return Dated October 2, 2026

Exhibit 99.4 — Next Day Disclosure Return Dated October 2, 2026

Exhibit 99.5 — Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities

Exhibit 99.6 — Next Day Disclosure Return Dated October 5, 2026

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	ZTO Express (Cayman) Inc.
	By	:	/s/ Huiping Yan
	Name	:	Huiping Yan
	Title	:	Chief Financial Officer

 

Date: October 5, 2026

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

EXHIBIT 99.2

EXHIBIT 99.3

EXHIBIT 99.4

EXHIBIT 99.5

EXHIBIT 99.6

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Goldman Sachs Downgrades ZTO Express Cayman (2057:HK) (ZTO) to Neutral
• Dott announces choice of home member state in relation to its bonds admitted to trading on Nasdaq Stockholm
• AltruBio Presents Phase 2a Data of ALTB-268 in Advanced Therapy-Refractory Ulcerative Colitis at UEG Week 2026